| Q40152460 | A modular treatment of molecular traffic through the active site of cholinesterase |
| Q28546253 | A wrench in the works of human acetylcholinesterase: soman induced conformational changes revealed by molecular dynamics simulations |
| Q43671271 | Accurate prediction of the bound conformation of galanthamine in the active site of Torpedo californica acetylcholinesterase using molecular docking |
| Q35538846 | Acetylcholinesterase: a multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer's disease |
| Q34176038 | Analysis of a 10-ns molecular dynamics simulation of mouse acetylcholinesterase |
| Q27667894 | Backdoor opening mechanism in acetylcholinesterase based on X-ray crystallography and molecular dynamics simulations |
| Q44651600 | Cage amines as the stopper inhibitors of cholinesterases |
| Q27641108 | Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibition |
| Q39125732 | Discovery of Species-selective and Resistance-breaking Anticholinesterase Insecticides for the Malaria Mosquito |
| Q53312777 | Docking of the alkaloid geissospermine into acetylcholinesterase: a natural scaffold targeting the treatment of Alzheimer's disease. |
| Q58290595 | Electrochemical Acetylcholine Chloride Biosensor Using an Acetylcholine Esterase Biomimic |
| Q46829757 | Evaluation of the 'side door' in carboxylesterase-mediated catalysis and inhibition |
| Q36838929 | Flexibility of aromatic residues in the active-site gorge of acetylcholinesterase: X-ray versus molecular dynamics |
| Q42870673 | Influence of the Acetylcholinesterase Active Site Protonation on Omega Loop and Active Site Dynamics |
| Q37029685 | Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine |
| Q27677846 | Kinetics of Torpedo californica acetylcholinesterase inhibition by bisnorcymserine and crystal structure of the complex with its leaving group |
| Q38884086 | Limitations in current acetylcholinesterase structure-based design of oxime antidotes for organophosphate poisoning. |
| Q27641615 | Malignant brain tumor repeats: a three-leaved propeller architecture with ligand/peptide binding pockets |
| Q47220501 | Molecular docking of different inhibitors and activators to butyrylcholinesterase |
| Q46845644 | Molecular docking study on the "back door" hypothesis for product clearance in acetylcholinesterase |
| Q45222504 | Ortho effects in quantitative structure-activity relationships for acetylcholinesterase inhibition by aryl carbamates |
| Q83835147 | Probing structure-function relationships of serine hydrolases and proteases with carbamate and thiocarbamate inhibitors |
| Q43210299 | Stereoselective inhibition of butyrylcholinesterase by enantiomers of exo- and endo-2-norbornyl-N-n-butylcarbamates |
| Q46783441 | Structural insights into conformational flexibility at the peripheral site and within the active center gorge of AChE. |
| Q27640254 | Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site |
| Q21090062 | Structure of HI-6*sarin-acetylcholinesterase determined by X-ray crystallography and molecular dynamics simulation: reactivator mechanism and design |
| Q46119907 | Structure-activity relationships and binding mode in the human acetylcholinesterase active site of pseudo-irreversible inhibitors related to xanthostigmine |
| Q45983116 | Synthesis of enantiomers of exo-2-norbornyl-N-n-butylcarbamate and endo-2-norbornyl-N-n-butylcarbamate for stereoselective inhibition of acetylcholinesterase. |
| Q27628948 | Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs |